| Generic Name | Originator | World Status | Any Pharmacology Description | Any Indication | Any Indication Status | Notes |
|---|---|---|---|---|---|---|
| fluoxetine, Flash Dose | Biovail | Pre-registration | 5 Hydroxytryptamine uptake
inhibitor 5 Hydroxytryptamine 2C antagonist |
Depression, general Anxiety, general Bulimia Premenstrual syndrome |
Pre-registration Pre-registration Pre-registration Pre-registration |
|
| sertraline | Pfizer | Launched | 5 Hydroxytryptamine uptake inhibitor | Depression, general Obsessive-compulsive disorder Panic disorder Post-traumatic stress disorder Premenstrual syndrome Social anxiety disorder Bulimia |
Launched Launched Launched Launched Launched Launched Phase II Clinical Trial |
|
| fluoxetine | Eli Lilly | Launched | 5 Hydroxytryptamine uptake
inhibitor 5 Hydroxytryptamine 2C antagonist |
Depression, general Anxiety, general Bulimia Premenstrual syndrome Obsessive-compulsive disorder |
Launched Launched Launched Launched Launched |
|
| Table 1 - Drug candidates under development, or developed for the treatment of bulimia. | ||||||